Axitan is a UK biotech company focused on eliminating antibiotics from animal feed and improving productivity. It is developing a library of endolysins, and associated products, capable of targeting those pathogens that impact livestock farming historically managed through antibiotic supplements in animal feed and, in so doing, improve productivityyields. Its focus forms part of wider WHO One Health initiative to combat the threat posed by antimicrobial resistance caused by the overuse of antibiotics, animals accounting for two thirds of the antibiotics consumed globally each year. In October 2022, Axitan achieved US FDA GRAS (“Generally Recognised As Safe”) status for the algal biomass ingredient used in its first product, FORC3®, which promotes healthy growth in poultry by targeting the pathogen Clostridium perfringens that causes $6b of economic loss each year to the poultry industry. Axitan has operations in the UK and US.
Company Details
- Employees
- 14
- Address
- Arlington Business Park, 1 Arlington Court,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://axitan.com/
- HQ
- Stevenage
Axitan Questions
Axitan's website is http://axitan.com/
Axitan's LinkedIn profile is https://www.linkedin.com/company/axitan
Axitan has
14 employees.
View email and phone details for 14
employees at Axitan.
Axitan's industry is
Biotechnology Research
Axitan's top competitors are
Fyto, Inc.,
Launch Bioindustries,
Qualitech,
Phycom,
Feed & Additive Magazine,
Qualitech • Animal Nutrition,
Novus International, Inc.,
Qponics Limited,
Pure Algae Denmark,
The Every Company.
Axitan's categories are Biotechnology Research
